Trinean Signs a Global Agreement with Bayer CropScience
News Jun 12, 2013
Trinean it has entered into a long-term agreement with Bayer CropScience to supply DropSense96 and Xpose droplet readers along with its proprietary cDrop spectral analysis software to Bayer CropScience's global operations. Bayer CropScience will be using Trineans technology for High Throughput quantification and quality control of isolated biomolecules to assure robust outcome of genetic tests in its molecular breeding program.
“Trinean is delighted to be a global supplier to Bayer CropScience. Our microfluidic technology matches the expectations of Bayer CropScience in terms of automation, minimal sample consumption and accurate quantification of a broad range of plant extracts.” said Yvan Sergeant, VP commercial operations of Trinean. “We are committed to helping Bayer CropScience reach its high standards in the genetic research and high-quality seeds for field and vegetable crops.”
A real challenge exists for all plant genetic labs to accurately quantify nucleic acid extracts from plant tissue due to variations in genome size and the presence of co-purified buffer components or plant metabolites influencing both the quantification result as well as downstream genetic tests. Unlike traditional methods, the Trinean technology performs an in-depth sample content analysis by profiling the measured UV/VIS absorbance spectrum for both the biomolecule of interest and interfering chemicals. This approach allows specific concentration determination and genuine purity analysis within a simple ‘drop & read’ approach.
New Approach Identifies Important Undiscovered Functions of ProteinsNews
Scientists have developed a new method to discover which surface contacts on proteins are critical for these cellular interactions. The novel approach shows that essential new functions can be uncovered even for well-studied proteins, and has significant implications for therapeutic drug development, which depends heavily on how drugs physically interact with their cellular targets.READ MORE
Children With Congenital Zika Virus Infection Face Serious Challenges as They AgeNews
The report from the CDC is the first to describe the health and developmental effects of congenital Zika virus infection in children with microcephaly through 2 years of age.READ MORE